The health care debate in the US has focused on a looming crisis, with millions possibly losing insurance coverage. In India, an immediate crisis looms with tuberculosis.
We've been told for a long time that we must take all of our antibiotics. But maybe we didn’t need so many to begin with. Here's why.
Despite being so small they can't be seen with the naked eye, pathogens that cause human disease have greatly affected the way humans live for centuries.
Here we explore our past and present struggles with four of the most significant infectious diseases human beings have faced, and some of the progress we've made in prevention and treatment.
About three million people globally are 'missed' each year for Tuberculosis diagnosis. Many of them will die, some will get better, others will continue to infect others.
The proposed foreign aid cuts by US President Donald Trump will have a devastating impact on healthcare in Africa.
In Australia, there are around 1200 to 1300 cases of tuberculosis each year which means we are among the lowest-risk countries in the world.
Scientists have struggled to diagnose TB in people with compromised immune systems because of the low levels of the bacteria in their body.
Tuberculosis transmitted from animals to humans is a growing concern in poor countries. As we observe World Tuberculosis Day, it's worth asking why.
Advanced lab tests have entered the market to improve tuberculosis diagnosis. This will ensure prompt and correct treatment in managing the disease.
To tackle TB a dynamic change in discourse is needed. The focus must be on how to respond to emerging complexities the disease presents.
Shortening the treatment period has become a top priority within TB research but studies to date have been unsuccessful.
Eradicating TB won't happen unless the number of people who are latent carriers is tackled. A new estimate suggests it's a much bigger problem than previously thought.
Antibiotics that were not originally earmarked to treat TB have shown the first signs of effectiveness and could be added to the much-needed arsenal of drugs to fight the deadly disease.
The burden of communicable disease is declining in Africa and life expectancy is increasing. But non-communicable diseases like diabetes, cardiovascular disease and cancer are wreaking havoc.
A new centre in South Africa will work to significantly reduce emerging HIV and TB co-infections.
Scientists have found proteins in the body that promote lung inflammation which helps the bacteria that causes TB to spread throughout the lung.
A new study shows that by using genomics, you can cut down the lengthy process of testing for drug-resistance TB to a matter of days.
African scientists have developed and patented a test for TB that overcomes two major challenges with current methods: it delivers quick results and is much cheaper.
Many people in the U.S. have no idea that TB is still found here, or what a major health risk it poses in other parts of the world.